Therapeutic Potential of Chinese Prescription Hachimi-Jio-Gan and Its Crude Drug Corni Fructus against Diabetic Nephropathy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Traditional plant drugs, are less toxic and free from side effects compared to general synthetic drugs. They have been used for the treatment of diabetes and associated renal damage. In this study, we evaluated effect of Hachimi-jio-gan against diabetic renal damage in a rat model of type 1 diabetic nephropathy induced by subtotal nephrectomy plus streptozotocin (STZ) injection, and in Otsuka Long-Evans Tokushima Fatty (OLETF) rats and db/db mice as a model of human type 2 diabetes, and its associated complications. To explore the active components of Hachimi-jio-gan, the antidiabetic effect of corni fructus, a consituent of Hachimi-jio-gan, and 7-O-galloyl-D-sedoheptulose, a phenolic compound isolated from corni fructus, were investigated. Methods and Results: We conducted an extensive literature search, and all required data were collected and systematically organized. The findings were reviewed and categorized based on relevance to the topic. A summary of all the therapeutic effects were reported as figures and tables. Conclusions: Hachimi-jio-gan serves as a potential therapeutic agent to against the development of type 1 and type 2 diabetic nephropathy. From the results of characterization active components of corni fructus, 7-O-galloyl-D-sedoheptulose is considered to play an important role in preventing and/or delaying the onset of diabetic renal damage. 7-O-Galloyl-D-sedoheptulose is expected to serve as a novel therapeutic agent against the development of diabetic nephropathy.
Abstract
Background: Traditional plant drugs, are less toxic and free from side effects compared to general synthetic drugs. They have been used for the treatment of diabetes and associated renal damage. In this study, we evaluated effect of Hachimi-jio-gan against diabetic renal damage in a rat model of type 1 diabetic nephropathy induced by subtotal nephrectomy plus streptozotocin (STZ) injection, and in Otsuka Long-Evans Tokushima Fatty (OLETF) rats and db/db mice as a model of human type 2 diabetes, and its associated complications. To explore the active components of Hachimi-jio-gan, the antidiabetic effect of corni fructus, a consituent of Hachimi-jio-gan, and 7-O-galloyl-D-sedoheptulose, a phenolic compound isolated from corni fructus, were investigated. Methods and Results: We conducted an extensive literature search, and all required data were collected and systematically organized. The findings were reviewed and categorized based on relevance to the topic. A summary of all the therapeutic effects were reported as figures and tables. Conclusions: Hachimi-jio-gan serves as a potential therapeutic agent to against the development of type 1 and type 2 diabetic nephropathy. From the results of characterization active components of corni fructus, 7-O-galloyl-D-sedoheptulose is considered to play an important role in preventing and/or delaying the onset of diabetic renal damage. 7-O-Galloyl-D-sedoheptulose is expected to serve as a novel therapeutic agent against the development of diabetic nephropathy.
참고문헌 (42)
- Adler S, "Structure-function relationships in diabetic nephropathy : Lessons and limitations", Kidney International, 60, pp.S42~S45 (1997)
- Babior BM, "The neutrophil NADPH oxidase", Archives of Biochemistry and Biophysics, 397, pp.342~344 (2002)
- Bell DSH, "Diabetic nephropathy : Changing concepts of pathogenesis and treatment", The American Journal of the Medical Sciences, 301, pp.195~200 (1991)
- Brenner BM, "RENAAL Study Investigators: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy", N Engl J Med, 345, pp.861~869 (2001)
- Brownlee M, "Nonenzymatic glycosylation and the pathogenesis of diabetic complications", Annals of Internal Medicine, 101, pp.527~537 (1984)
- Chang JS, "Chemoprevention against hepatocellular carcinoma of Cornus officinalis in vitro", The American Journal of Chinese Medicine, 32, pp.717~725 (2004)
- Cooper ME, "Pathophysiology of diabetic nephropathy", Metabolism, 47, pp.3~6 (1998)
- Fukami K, "AGEs activate mesangial TGF-β-Smad signaling via an angiotensin II type I receptor interaction", Kidney International, 66, pp.2137~2147 (2004)
- Furuya Y, "Effect of Hachimijio-gan(Ba-Wei-Di-Huang-Wan)on insulin resistance in noninsulin dependent diabetes mellitus model mice", Journal of Traditional Medicines, 16, pp.123~128 (1999)
- Geiszt M, "Identification of redox, an NAD(P)H oxidase in kidney", Proceedings of the National Academy of Sciences of the United States of America, 97, pp.8010~8014 (2000)
- Gill PS, "NADPH oxidases in the kidney", Antioxidants and Redox Signaling, 8, pp.1597~1607 (2006)
- Goto M, "Comparative effects of traditional Chinese medicines(Dai-saiko-to, Hatimi-zio-gan and Byakko-ka-ninzin-to)on experimental diabetes and hyperlipidemia", Nihon Yakurigaku Zasshi, 93, pp.179~186 (1989)
- Heart Outcomes Prevention Evaluation(HOPE) Study Investigators, "Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus:Results of the HOPE study and MICRO-HOPE substudy", The Lancet, 355, pp.253~259 (2000)
- Huang T, "A handbook of traditional Chinese prescriptions of dubious and complicated cases", pp.527~538 (1997), China Medical and Pharmaceutical Science and Technology Publishing House
- Kaneda M, "Chemical studies on the oriental plant drugs-XXXIII : The absolute structures of paeoniflorin, albiflorin, oxypaeoniflorin and benzoylpaeoniflorin isolated from chinese paeony root", Tetrahedron, 28, pp.4309~4317 (1972)
- Kawano K, "Spontaneous long-term hyperglycemic rat with diabetic complications : Otsuka Long-Evans Tokushima Fatty(OLETF)strain", Diabetes, 41, pp.1422~1428 (1992)
- Lee HB, "Reactive oxygen species-regulated signaling pathways in diabetic nephropathy", Journal of the American Society of Nephrology, 14, pp.S241~S245 (2003)
- Lehmann R, "Molecular mechanism of diabetic nephropathy", Clinica Chimica Acta, 297, pp.135~144 (2000)
- Lewis EJ, "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes", The New England Journal of Medicine, 345, pp.851~860 (2001)
- Liou SS, "Corni fructus as the major herb of Die-huang-wan for lowering plasma glucose in Wistar rats", Journal of Pharmacy and Pharmacology, 56, pp.1443~1447 (2004)
- Nakagawa T, "A study of Kampo medicines in a diabetic nephropathy model", Journal of Traditional Medicines, 18, pp.161~168 (2001)
- Nakagawa T, "Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy", Journal of Pharmacy and Pharmacology, 55, pp.219~227 (2003)
- Nath KA, "Reactive oxygen species and acute renal failure", The American Journal of Medicine, 109, pp.665~678 (2000)
- 박찬흠, "Protection Against Hypercholesterolemia by Corni Fructus Extract and Its Related Protective Mechanism", Journal of Medicinal Food, 12(5), pp.973~981 (2009), 한국식품영양과학회
- Park CH, "7-OGalloyl-D-sedoheptulose ameliorates renal damage triggered by reactive oxygen species-sensitive pathway of inflammation and apoptosis", Journal of Pharmacy and Pharmacology, 64, pp.1730~1740 (2012)
- "Beneficial effect of 7-O-galloyl-D-sedoheptulose, a polyphenol isolated from corni fructus, against diabetes-induced alterations in kidney and adipose tissue of type 2 dianetic db/db mice" (2013)[URL]
- Remuzzi G, "Pathophysiology of progressive nephropathies", The New England Journal of Medicine, 339, pp.1448~1456 (1998)
- Sedeek M, "Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney : Implications in type 2 diabetic nephropathy", American Journal of Physiology-Renal Physiology, 299, pp.F1348~F1358 (2010)
- Sharma K, "Diabetic kidney disease in the db", db mouse, 2003, pp.284, F1138~F1144
- Shiose A, "A novel superoxide-producing NAD(P)H oxidase in kidney", Journal of Biological Chemistry, 276, pp.1417~1423 (2001)
- UK Prospective Diabetes Study, "Intensive blood-glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33)", The Lancet, 352, pp.837~853 (1998)
- Vareed SK, "Anthocyanins in Cornus alternifolia, Cornus controversa, Cornus kousa and Cornus florida fruits with health benefits", Life Sciences, 78, pp.777~784 (2006)
- Wang SF, "Analysis of three effective components in fructus corni and its preparations by micellar electrokinetic capillary chromatography", Biomedical Chromatography, 17, pp.306~311 (2003)
- Winetz JA, "Glomerular function in advanced human diabetic nephropathy", Kidney International, 21, pp.750~756 (1982)
- Yamabe N, "Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima Fatty rat : A model of human type 2diabetes mellitus", Journal of Pharmacy and Pharmacology, 58, pp.535~545 (2006)
- Yamabe N, "Beneficial effect of corni fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in streptozotocin-treated diabetic rats", Biological and Pharmaceutical Bulletin, 30, pp.520~526 (2007)
- Yamada T, "Kinki Yoryaku", pp.1~7 (1992), Kyouwa-Kikaku
- Yaqoob M, "Evidence of oxidant injury and tubular damage in early diabetic nephropathy", QJM An International Journal of Medicine, 87, pp.601~607 (1994)
- Yokozawa T, "Effects of oriental medicines on the production of advanced glycation end products", Journal of Traditional Medicines, 18, pp.107~112 (2001)
- Yokozawa T, "Animal model of diabetic nephropathy", Experimental and Toxicologic Pathology, 53, pp.359~363 (2001)
- Yokozawa T, "A study on the effects to diabetic nephropathy of Hachimi-jio-gan in rats", Nephron Experimental Nephrology, 97, pp.e38~e48 (2004)
- Yokozawa T, "Amelioration of diabetic nephropathy by dried rehmanniae radix(Di-huang)extract", The American Journal of Chinese Medicine, 32, pp.829~839 (2004)